China Pharma Holdings, Inc. Overview
Pro stress-test →China Pharma Holdings is a fully-integrated specialty pharmaceuticals company in China. The company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC.
Strategic Profile
Pro stress-test →The company's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The company operates with limited financial visibility and faces significant stock price volatility; the share price declined from $2.90 in March 2025 to $0.63 in March 2026, representing a 78.29% decline.
Competitive Landscape
Pro stress-test →China Pharma competes in the generic and branded pharmaceutical market in China against established domestic and international pharmaceutical companies. The company focuses on specialty products for high-incidence diseases, but faces intense competition from larger, better-capitalized competitors with broader product portfolios and stronger distribution networks.
Industry Context
China Pharma Holdings, Inc. operates in Generic and branded pharmaceuticals (China).
Key facts
Founded: N/A · Headquarters: Haikou, China · Employees: N/A · Revenue: N/A · Market cap: N/A